NCT00125944View on ClinicalTrials.gov

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

January 31, 2006

Conditions
HealthyInfluenza
Interventions
BIOLOGICAL

FluMist

Trial Locations (4)

32114

Radiant Research, Daytona Beach, Daytona Beach

78229

Healthcare Discoveries, Inc., San Antonio

92123

Radiant Research, San Diego, San Diego

97239

Radiant Research, Portland

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY